Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04109066
Title Study of Nivolumab Versus Placebo in Participants With High-Risk Breast Cancer (CheckMate 7FL)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb

estrogen-receptor positive breast cancer



Anthracycline + Cyclophosphamide + Nivolumab

Nivolumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

No variant requirements are available.